相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
Cheryl M. Koh et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
TERT promoter mutations and telomerase reactivation in urothelial cancer
Sumit Borah et al.
SCIENCE (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
Mohamed Ali Mosrati et al.
ONCOTARGET (2015)
Catalytically inactive telomerase in oncogenesis
Vinay Tergaonkar
ONCOTARGET (2015)
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase
Anagha Killedar et al.
PLOS GENETICS (2015)
Telomerase Reverse Transcriptase Has an Extratelomeric Function in Somatic Cell Reprogramming
Taisuke Kinoshita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
An Investigation of the Effects of the Core Protein Telomerase Reverse Transcriptase on Wnt Signaling in Breast Cancer Cells
Imke Listerman et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Involvement of Telomerase Reverse Transcriptase in Heterochromatin Maintenance
Yoshiko Maida et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells
Satoko Yamaguchi et al.
PLOS ONE (2014)
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA (2013)
The Major Reverse Transcriptase-Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
Imke Listerman et al.
CANCER RESEARCH (2013)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen et al.
NATURE GENETICS (2013)
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells
Z. Liu et al.
ONCOGENE (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis
Angela Queisser et al.
CANCER GENETICS (2013)
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Jian Hu et al.
CELL (2012)
Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells
Erhong Meng et al.
GYNECOLOGIC ONCOLOGY (2012)
Alternatively Spliced Telomerase Reverse Transcriptase Variants Lacking Telomerase Activity Stimulate Cell Proliferation
Radmila Hrdlickova et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Wnt/β-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells
Katrin Hoffmeyer et al.
SCIENCE (2012)
Telomere Length Is Related to Alternative Splice Patterns of Telomerase in Thyroid Tumors
Yongchun Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
Naoko Okamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
Immanual Joseph et al.
CANCER RESEARCH (2010)
A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
John Nemunaitis et al.
MOLECULAR THERAPY (2010)
Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab
Erin M. Goldblatt et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Argonaute CSR-1 and Its 22G-RNA Cofactors Are Required for Holocentric Chromosome Segregation
Julie M. Claycomb et al.
CELL (2009)
The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel
Erin M. Goldblatt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Telomerase modulates Wnt signalling by association with target gene chromatin
Jae-Il Park et al.
NATURE (2009)
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Yoshiko Maida et al.
NATURE (2009)
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
Thorunn Rafnar et al.
NATURE GENETICS (2009)
Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines
D. Parsch et al.
CANCER INVESTIGATION (2008)
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Satoru Kyo et al.
CANCER SCIENCE (2008)
Structure of the Tribolium castaneum telomerase catalytic subunit TERT
Andrew J. Gillis et al.
NATURE (2008)
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes
Toshiaki Watanabe et al.
NATURE (2008)
Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes
Oliver H. Tam et al.
NATURE (2008)
TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program
Jinkuk Choi et al.
PLOS GENETICS (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Distinct populations of primary and secondary effectors during RNAi in C-elegans
Julia Pak et al.
SCIENCE (2007)
Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer
Eleni Mavrogiannou et al.
CLINICAL CHEMISTRY (2007)
Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells
Dennis Gomez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The structure of an RNAi polymerase links RNA silencing and transcription
Paula S. Salgado et al.
PLOS BIOLOGY (2006)
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer
Amelia E. Hochreiter et al.
CLINICAL CANCER RESEARCH (2006)
G-quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells
H Tahara et al.
ONCOGENE (2006)
Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer
GC Gellert et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Effects of telomerase and telomere length on epidermal stem cell behavior
I Flores et al.
SCIENCE (2005)
Conditional telomerase induction causes proliferation of hair follicle stem cells
KY Sarin et al.
NATURE (2005)
Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition
BS Herbert et al.
ONCOGENE (2005)
RNA-dependent RNA polymerase is an essential component of a self-enforcing loop coupling heterochromatin assembly to siRNA production
T Sugiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Interaction of telomestatin with the telomeric single-strand overhang
D Gomez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition
OE Bechter et al.
CANCER RESEARCH (2004)
Cellular RNA-dependent RNA polymerase involved posttranscriptional gene silencing has two distinct activity modes
EV Makeyev et al.
MOLECULAR CELL (2002)
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity
N Zaffaroni et al.
JOURNAL OF PATHOLOGY (2002)
Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate
E Pascolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A highly selective telomerase inhibitor limiting human cancer cell proliferation
K Damm et al.
EMBO JOURNAL (2001)